Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Go Gang / Klinik for Fodterapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   0.0% 0.0% 5.8% 6.2% 8.5% 9.4% 9.7% 9.3%   Credit score (0-100)   0 0 39 37 28 25 25 26   Credit rating   N/A N/A BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 407 611 527 517 0.0 0.0   EBITDA   0.0 0.0 284 158 58.3 122 0.0 0.0   EBIT   0.0 0.0 211 43.6 -56.2 5.4 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 210.9 30.7 -67.4 2.3 0.0 0.0   Net earnings   0.0 0.0 163.7 14.6 -62.5 -1.6 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 211 30.7 -67.4 2.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 304 251 177 111 0.0 0.0   Shareholders equity total   0.0 0.0 204 218 156 154 114 114   Interest-bearing liabilities   0.0 0.0 122 51.8 53.3 40.8 139 139   Balance sheet total (assets)   0.0 0.0 839 777 624 614 253 253   Net Debt   0.0 0.0 106 5.6 35.2 35.3 139 139     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 407 611 527 517 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 50.1% -13.7% -1.9% -100.0% 0.0%   Employees   0 0 1 1 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 839 777 624 614 253 253   Balance sheet change%   0.0% 0.0% 0.0% -7.3% -19.8% -1.6% -58.7% 0.0%   Added value   0.0 0.0 284.5 158.1 58.3 122.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 604 -207 -229 -223 -111 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 51.9% 7.1% -10.7% 1.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 25.2% 5.4% -8.0% 0.9% 0.0% 0.0%   ROI %   0.0% 0.0% 62.2% 14.0% -22.2% 2.5% 0.0% 0.0%   ROE %   0.0% 0.0% 80.4% 6.9% -33.4% -1.1% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 24.3% 28.1% 25.0% 25.1% 45.1% 45.1%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 37.1% 3.5% 60.4% 29.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 59.6% 23.7% 34.2% 26.5% 121.7% 121.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.1% 14.8% 21.3% 6.5% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0   Current Ratio   0.0 0.0 0.2 0.3 0.2 0.5 0.0 0.0   Cash and cash equivalent   0.0 0.0 15.9 46.2 18.1 5.5 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 -510.8 -384.6 -325.5 -217.1 -69.5 -69.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 284 158 29 61 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 284 158 29 61 0 0   EBIT / employee   0 0 211 44 -28 3 0 0   Net earnings / employee   0 0 164 15 -31 -1 0 0